Display options
Cite
Aleo MD, Shah F, He K, et al. Correction to Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals. Chem Res Toxicol. 2017;30(6):1365doi: 10.1021/acs.chemrestox.7b00124.
Aleo, M. D., Shah, F., He, K., Bonin, P. D., & Rodrigues, A. D. (2017). Correction to Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals. Chemical research in toxicology, 30(6), 1365. https://doi.org/10.1021/acs.chemrestox.7b00124
Aleo, Michael D, et al. "Correction to Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals." Chemical research in toxicology vol. 30,6 (2017): 1365. doi: https://doi.org/10.1021/acs.chemrestox.7b00124
Aleo MD, Shah F, He K, Bonin PD, Rodrigues AD. Correction to Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals. Chem Res Toxicol. 2017 Jun 19;30(6):1365. doi: 10.1021/acs.chemrestox.7b00124. Epub 2017 May 18. PMID: 28520417.
Copy Download .nbib Format: NLM
Share it on

Chem Res Toxicol. 2017 Jun 19;30(6):1365. doi: 10.1021/acs.chemrestox.7b00124. Epub 2017 May 18.

Correction to Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.

Chemical research in toxicology

Michael D Aleo, Falgun Shah, Kan He, Paul D Bonin, A David Rodrigues

PMID: 28520417 DOI: 10.1021/acs.chemrestox.7b00124

[No abstract available.]

Publication Types